Authors: ZACHARIAE H ABRAMS B BLEEHEN SS BRAUTIGAM M BURROWS D ETTELT MJ FRY L HAPPLE R HAUSTEIN UF GANSLANDT J JUNG EG KNOP J KUHNE KH MELLEIN B MORK NJ ROGERS S SCHMIDT AG SCHOPF RE SUMNER M TAUBE KM WEIDINGER G WURDEL C ZAHN E

Citation: H. Zachariae et al., CONVERSION OF PSORIASIS PATIENTS FROM THE CONVENTIONAL FORMULATION OFCYCLOSPORINE-A TO A NEW MICROEMULSION FORMULATION - A RANDOMIZED, OPEN, MULTICENTER ASSESSMENT OF SAFETY AND TOLERABILITY, Dermatology, 196(2), 1998, pp. 231-236

Authors: MUELLER EA NIESE D MELLEIN B

Citation: Ea. Mueller et al., CYCLOSPORINE MICROEMULSION FORMULATION (NEORAL) IN TRANSPLANTATION - PHARMACOKINETIC PHARMACODYNAMIC RELATIONSHIPS/, Transplantation proceedings, 30(5), 1998, pp. 1694-1696

Authors: FEUTREN G WONG R JIN J NIESE D MELLEIN B

Citation: G. Feutren et al., SAFETY AND TOLERABILITY OF NEORAL IN TRANSPLANT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2177-2182